前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービス
文献複写のお申込み
JDreamⅢ複写サービスのご利用が初めての方
学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201802226963245868   整理番号：18A1005048

全身性リウマチ疾患患者におけるニューモシスチス肺炎の化学予防のためのスルファメトキサゾール-トリメトプリムの最適処方:非盲検無作為化対照試験からの結果【JST・京大機械翻訳】

Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
著者 (46件)：
Utsunomiya Masako
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Utsunomiya Masako
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Utsunomiya Masako
(Department of Rheumatology, Musashino Red Cross Hospital, Tokyo, Japan)
, 
Dobashi Hiroaki
(Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kida-gun, Japan)
, 
Odani Toshio
(Third Department of Internal Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan)
, 
Odani Toshio
(Department of Internal Medicine, Hokusei Hospital, Chitose, Japan)
, 
Saito Kazuyoshi
(First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan)
, 
Yokogawa Naoto
(Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan)
, 
Nagasaka Kenji
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Nagasaka Kenji
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Nagasaka Kenji
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
, 
Takenaka Kenchi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Takenaka Kenchi
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
, 
Soejima Makoto
(Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan)
, 
Soejima Makoto
(Department of Rheumatology, Soka Municipal Hospital, Soka, Japan)
, 
Sugihara Takahiko
(Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan)
, 
Hagiyama Hiroyuki
(Department of Rheumatology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan)
, 
Hirata Shinya
(Department of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Graduate School of Medicine, Kumamoto, Japan)
, 
Matsui Kazuo
(Department of Rheumatology, Kameda Medical Center, Kamogawa, Japan)
, 
Matsui Kazuo
(Department of Internal Medicine, Takikawa Municipal Hospital, Takikawa, Japan)
, 
Nonomura Yoshinori
(Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan)
, 
Kondo Masahiro
(Department of Rheumatology, Faculty of Medicine, Shimane University, Izumo, Japan)
, 
Suzuki Fumihito
(Department of Rheumatology, Soka Municipal Hospital, Soka, Japan)
, 
Suzuki Fumihito
(Department of Rheumatology, JA Toride Medical Center, Toride, Japan)
, 
Tomita Makoto
(Clinical Research Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan)
, 
Kihara Mari
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Kihara Mari
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Yokoyama Waka
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Yokoyama Waka
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Hirano Fumio
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Hirano Fumio
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Yamazaki Hayato
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Yamazaki Hayato
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Sakai Ryoko
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Sakai Ryoko
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Sakai Ryoko
(Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan)
, 
Nanki Toshihiro
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Nanki Toshihiro
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Nanki Toshihiro
(Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan)
, 
Koike Ryuji
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Koike Ryuji
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Kohsaka Hitoshi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Miyasaka Nobuyuki
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Harigai Masayoshi
(Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Harigai Masayoshi
(Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan)
, 
Harigai Masayoshi
(Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan)

資料名：
Arthritis Research & Therapy (Web)  (Arthritis Research & Therapy (Web))

巻： 19  号： 1  ページ： 7  発行年： 2017年 
JST資料番号： U7412A  ISSN： 1478-6362  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： イギリス (GBR)  言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

Copyright (c) 2009 Japan Science and Technology Agency. All Rights Reserved

TOP

BOTTOM